Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 99376
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99376
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99376
Figure 1 IC50 determination of BIBR1532 in esophageal squamous cell carcinoma cells.
A and B: Viability of KYSE150 (A) and KYSE410 (B) cells after treatment with the indicated concentrations of BIBR1532 for 48 hours; C and D: Viability of KYSE150 (C) and KYSE410 (D) cells after treatment with the indicated concentrations of BIBR1532 for 72 hours.
- Citation: Wang Q, Li QR, Xu L, Yuan ZC, Liu X, Tang MJ, Luo M, Zhong XW, Ma Q, Guo XL. BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. World J Gastrointest Oncol 2025; 17(1): 99376
- URL: https://www.wjgnet.com/1948-5204/full/v17/i1/99376.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i1.99376